MOVEMovano Inc.

Nasdaq movano.com


$ 0.44 $ -0.05 (-11.5 %)    

Wednesday, 08-May-2024 10:07:22 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 0.4
$ 0.44
$ 0.00 x 0
$ 0.00 x 0
$ 0.44 - $ 0.44
$ 0.37 - $ 1.50
104,233
na
3.4M
$ 0.80
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-16-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kura-sushi-greenbrier-and-3-stocks-to-watch-heading-into-friday

With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as fol...

 movano-says-focuses-on-2024-strategic-pathway-to-fda-clearances-driving-b2b-opportunities-executes-24m-funding-extending-cash-runway

The company held $6.1 million in cash and cash equivalents at December 31, 2023. This week, the company signed an agreement for...

 movano-q4-eps-011-up-from-024-yoy

Movano (NASDAQ:MOVE) reported quarterly losses of $(0.11) per share. This is a 54.17 percent increase over losses of $(0.24) pe...

 earnings-scheduled-for-april-4-2024

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on r...

 movano-health-secured-strategic-investment-from-tier-one-multi-billion-dollar-medical-device-company

 Movano Health (NASDAQ:MOVE), a pioneer in health technology, secured a strategic investment from a tier-one multi-billion doll...

 reported-earlier-evie-rings-pulse-oximeter-exceeds-fda-accuracy-guidelines-in-movano-healths-second-hypoxia-trial

The Evie Ring entered commercial production in late 2023 as a consumer wellness device. This latest UCSF study, completed in th...

 movano-has-received-a-notice-of-allowance-for-its-us-patent-application-16682780-titled-methods-for-monitoring-a-blood-glucose-level-in-a-person-using-radio-waves

https://patentcenter.uspto.gov/applications/16682780/ifw/docs 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION